

FDA Officials Speak Out: New Approvals & Safety Concerns Discussed

Patients on Dialysis Taking Denosumab May Be at Risk of Severe Hypocalcemia

CORRONA: History & Lessons Learned

ACR-FDA Summit Focuses on Study Design, Safety Considerations

The Great Debate: Belimumab vs. Voclosporin in Lupus Nephritis

FDA Discussed 2021 Drug Warnings & Approvals at ACR Annual Meeting

Trial Pits Upadacitinib vs. Adalimumab for Psoriatic Arthritis

Tips for Transitioning Patients from Pediatric to Adult Rheumatology Care

FDA Requires New Boxed Warnings on JAK Inhibitors, Places Restrictions on Use
- 1
- 2
- 3
- …
- 19
- Next Page »